KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Treasury Shares (2017 - 2025)

Guardant Health's Treasury Shares history spans 1 years, with the latest figure at $45.0 million for Q3 2025.

  • For Q4 2025, Treasury Shares fell 0.76% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, down 0.76%, while the annual FY2025 figure was $1.3 million, 0.76% down from the prior year.
  • Treasury Shares for Q4 2025 was $1.3 million at Guardant Health, up from $976351.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $5.0 million in Q3 2024 and bottomed at $396179.0 in Q1 2021.
  • The 5-year median for Treasury Shares is $1.4 million (2021), against an average of $1.9 million.
  • The largest annual shift saw Treasury Shares soared 533.98% in 2022 before it plummeted 88.82% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $1.5 million in 2021, then skyrocketed by 146.1% to $3.7 million in 2022, then plummeted by 88.82% to $412490.0 in 2023, then surged by 212.9% to $1.3 million in 2024, then fell by 0.76% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Treasury Shares are $45.0 million (Q3 2025), $45.0 million (Q2 2025), and $45.0 million (Q1 2025).